Cancer vans bring genetic testing to women who need it most

NCT ID NCT05649072

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to find women in Texas who are at risk for hereditary breast, ovarian, and colorectal cancers but have limited access to healthcare. Researchers will use mobile mammography units to offer genetic testing and counseling on the spot. Up to 1,000 women will provide a saliva sample and answer questions to see if they qualify for standard genetic counseling. The goal is to catch cancer risk early in underserved communities.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
genetic testing and counseling
What this could lead to
If successful, this could help find more women at high risk for hereditary cancers who might otherwise be missed, enabling earlier prevention or treatment.
What could go wrong
This is an observational screening study, not a treatment trial. It may not directly improve health outcomes, and participation could cause anxiety or require follow-up that is not always available.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • M D Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.